Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Polish Archives of Internal Medicine, adding:
”The VAS Group is pleased to announce the publication of our latest review article in the Polish Archives of Internal Medicine (PAIM):
‘Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction’
This is an updated overview of the evolving landscape of genetic risk assessment in venous thromboembolism (VTE), moving from conventional inherited thrombophilia testing toward next-generation genomic and polygenic risk prediction approaches.
Key messages of the review include:
- The complex interaction between genetic, acquired, and environmental determinants of VTE
- The current and future role of classical thrombophilia testing (Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies)
- The emergence of genome-wide association studies (GWAS)-derived polygenic risk scores as innovative tools for individualized VTE risk stratification
- The potential integration of genomic medicine into precision thrombosis prevention and management
- The major scientific and clinical barriers that still limit implementation in routine clinical practice
This publication highlights the growing importance of precision medicine and translational vascular science in the management of thrombotic disease.
Congratulations and sincere thanks to all co-authors and collaborators for this excellent international collaborative work.”
Title: Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction
Authors: Benilde Cosmi, Grigoris Gerotziafas, Peter Marschang, Matija Kozak, Mariella Catalano, Agata Stanek

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy